The 1 analysts offering 12-month price forecasts for Artelo Biosciences Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +550.41% increase from the last price of 1.23.
The current consensus among 1 polled investment analysts is to Hold stock in Artelo Biosciences Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.36
Reporting Date Nov 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.